Vaccination

Third virus vaccine reaches major hurdle: final US testing

A handful of the dozens of experimental COVID-19 vaccines in human testing have reached the last and biggest hurdle—looking for the needed proof that they really work as a U.S. advisory panel suggested Tuesday a way to ...

Vaccination

The science and economics of COVID-19 vaccines

A mad race to produce a vaccine against COVID-19 has begun with the world's superpowers leading the pack. At stake are millions of lives and billions of dollars.

Medical economics

German vaccine maker CureVac surges almost 250% in Nasdaq debut

Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.

Diseases, Conditions, Syndromes

WHO urges countries to gamble on shared vaccine search

The WHO on Thursday urged countries to invest billions of dollars in searching for COVID-19 vaccines and treatments—calling it a snip compared to the vast economic cost of the coronavirus crisis.

page 26 from 40